Infectious Disease

Pathogens, stewardship and the response to emerging threats.

Nova Scotia Cryptococcus gattii Cases Point to Local Endemicity

Six confirmed Cryptococcus gattii infections in Nova Scotia, mostly VGIIb and often without travel, support local acquisition and severe CNS disease.

By Dr. A.R. Athira, MBBS · Nov 3, 2026 · 5 min read

Infectious Disease·STAT

FDA Approves Generic Lenacapavir for HIV Prevention Access

Dr. Reddy’s won tentative FDA approval for a generic HIV prevention shot, a step toward lower-cost access in…

Nov 3, 2026

Infectious Disease·CDC EID

Cryptosporidium hominis IfA12G1R5 surges in Spain after COVID-19

Spanish molecular surveillance found a postpandemic rise in hypertransmissible Cryptosporidium hominis IfA12G1R5, with C. parvum staying relatively stable.

Nov 3, 2026

Infectious Disease·PLOS Med

HIV provirus transcription reprograms T cells to persist under ART

Defective HIV proviruses remain transcriptionally active and can rewire infected CD4 T cells, promoting survival and clonal persistence…

Nov 2, 2026

Infectious Disease·CID

Rapid AST for Bloodstream Infections Improves Antibiotic Decisions

Rapid antimicrobial susceptibility testing shortens results time in bloodstream infections and can improve antibiotic decisions, though randomized outcome…

Nov 2, 2026

Infectious Disease·JAMA

HIV Initial Therapy Trial Compares Weight Gain Across Two Regimens

A randomized HIV trial compares doravirine-based therapy with dolutegravir and tenofovir alafenamide for weight gain and viral suppression.

Nov 2, 2026

Infectious Disease·FDA

EBV Rash Mimicked Secondary Syphilis After Sequential Antibiotics

A late-20s man with acute EBV developed a palm-and-sole rash after multiple antibiotics, complicating the differential with syphilis…

Nov 2, 2026

Infectious Disease·WHO

Protein Structure Improves Prediction of Tuberculosis Antibiotic Resistance

Structural mapping of Mycobacterium tuberculosis mutations improved resistance prediction, with clustered variants and high classifier performance on held-out…

Nov 2, 2026

Infectious Disease·DailyMed

Vancomycin label warns of infusion reactions, AKI, and resistance

Updated vancomycin labeling reinforces diluted IV administration, renal monitoring, organism coverage, and the risk of severe infusion reactions.

Nov 1, 2026

Infectious Disease·Cancer Cell

Murine Toscana Virus Model Protocol Advances Skin Cell Analysis

Cell Press outlines a protocol for a murine Toscana virus infection model with downstream analysis of skin tissue…

Nov 1, 2026

Infectious Disease

Pathogens, stewardship and the response to emerging threats.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.